论文部分内容阅读
目的通过评估影像资料和临床预后来探讨血管内治疗巨大海绵窦段动脉瘤的安全性和有效性。方法回顾性分析2006年1月~2012年2月,连续接诊的行血管内治疗的巨大海绵窦段动脉瘤患者的临床和影像资料及随访结果。分析评价手术的可行性、手术并发症及影像和临床预后。结果共有27例患者27个巨大海绵窦段动脉瘤行血管内治疗。其中17例行载瘤动脉闭塞,8例支架辅助弹簧圈栓塞,2例单纯弹簧圈栓塞,术后即刻造影显示完全栓塞率、近全栓塞率和部分栓塞率分别为81.5%、11.1%和7.4%。无死亡病例,手术相关并发症发生率为7.4%。在为期32.9±17.3个月(4~71个月)的随访中,25例(92.6%)的预后良好(mRS评分0~1分),统计学分析显示高龄(60岁以上)与不良预后相关(P=0.006)。结论血管内治疗巨大海绵窦段动脉瘤安全有效,有症状的巨大海绵窦段动脉瘤应及时治疗,对于高龄患者治疗应慎重。
Objective To evaluate the safety and efficacy of endovascular treatment of giant aneurysm aneurysms by evaluating the imaging data and clinical prognosis. Methods The clinical and imaging data and follow-up results of consecutive patients undergoing endovascular treatment of giant cavernous aneurysm from January 2006 to February 2012 were retrospectively analyzed. Analysis and evaluation of the feasibility of surgery, surgical complications and imaging and clinical prognosis. Results A total of 27 patients with 27 giant cavernous aneurysms were treated with endovascular treatment. Twenty-seven of them had occlusion of nodal artery, 8 cases of stent-assisted coil embolization and 2 cases of simple coil embolization. Immediate embolization showed complete embolization rate, near-complete embolization rate and partial embolization rate of 81.5%, 11.1% and 7.4 %. No deaths occurred, and the incidence of surgery-related complications was 7.4%. In a follow-up period of 32.9 ± 17.3 months (range, 4 to 71 months), 25 (92.6%) had good outcomes (mRS score 0 to 1) and statistical analysis showed that older (over 60 years) was associated with poor prognosis (P = 0.006). Conclusions Endovascular treatment of giant cavernous aneurysm is safe and effective. Symptomatic giant cavernous aneurysm should be treated in time and caution should be taken for the treatment of elderly patients.